Updated March 26, 2026, 4:43 p.m. ET
- Studies show tirzepatide leads to significantly more weight loss on average compared to semaglutide.
- Tirzepatide and semaglutide are both FDA-approved weekly injections for weight management and type 2 diabetes.
- While both medications target the GLP-1 hormone, tirzepatide also targets the GIP hormone.
- Both drugs share similar side effects, primarily gastrointestinal issues like nausea and diarrhea.
Whether because you’ve overheard a family member casually sharing their results, or scrolled past a social media post about a celebrity’s dramatic recent weight loss, chances are you’re familiar with weight loss medications like Wegovy, Ozempic, Mounjaro and Zepbound, or even subscriptions like Hers, Ro and Medvi.
But behind these buzzy brand names are two very distinct drugs: tirzepatide and semaglutide. But what’s the difference between the two, and does it matter?
Below, board-certified doctors and registered dietitians share must-know info on how these two increasingly popular medications differ, including the cost, side effects, benefits and more.
Tirzepatide versus semaglutide at a glance
Both tirzepatide and semaglutide fall into the same class of medications: GLP-1 (glucagon-like peptide-1) receptor agonists (a substance that binds to your receptors and mimics a natural process) and are given via weekly injections. Both are FDA-approved for the management of type 2 diabetes and chronic weight management.
Despite these similarities, the fundamental difference between these medications is how they work, says Dr. Shannon Chatham, DO, a board-certified family medicine physician and medical director at Wisp. Semaglutide only targets one hormone: GLP-1. Tirzepatide, on the other hand, targets both GLP-1 and a second hormone called GIP (glucose-dependent insulinotropic polypeptide).
Dr. Asad Niazi, MD, Medical Advisor at Shed, explains how these two drugs work: “Semaglutide turns down hunger signals, while tirzepatide turns down hunger signals and improves how the body handles glucose and insulin at the same time.”
In other words, GLP-1 affects areas of the brain that regulate appetite, sending signals that make you feel full while slowing down the rate at which your stomach empties. GIP, meanwhile, plays a more direct role in warding off post-meal blood sugar spikes, while helping the body to break down fat more efficiently. Together, this combination helps your body lose and manage weight.
Here’s a basic rundown of tirzepatide versus semaglutide:
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Brand names | Ozempic, Wegovy | Mounjaro, Zepbound |
| How it works | Makes you feel fuller longer and suppresses appetite | Makes you feel fuller longer, suppresses appetite and lowers blood sugar |
| Hormones targeted | GLP-1 hormone receptors | GLP-1 and GIP hormone receptors |
| FDA-approved for weight loss | Yes (chronic weight management) | Yes (chronic weight management) |
| Common side effects | Nausea, diarrhea, vomiting, constipation, indigestion, abdominal pain, fatigue | Nausea, diarrhea, vomiting, constipation, indigestion, abdominal pain, fatigue |
| Cost | $900 – $1,700 per month without insurance | $1,000 – $1,200 per month without insurance |
| Average weight loss (after 1 year) | 8.3% | 15.3% |
Tirzepatide vs. semaglutide: Which is better for weight loss?
In the battle between tirzepatide versus semaglutide, tirzepatide is the clear winner for weight loss. On average, people on tirzepatide can lose almost twice as much weight as people on semaglutide, according to recent studies:
- A 2025 study compared the effectiveness of tirzepatide and semaglutide in patients with obesity. Researchers found that after 72 weeks of use, semaglutide caused an average of 13.7% weight loss, whereas tirzepatide caused an average of 20.2% weight loss.
- A study from 2024 also showed that people on tirzepatide were more likely to experience greater weight loss. After three months, tirzepatide users lost 5.9% of their body weight, while semaglutide users lost 3.6% of their body weight. By one year, tirzepatide users had lost 15.3% of their body weight, while semaglutide users had lost 8.3% of their body weight.
All that said, the medication that yields the best weight loss benefits for you may depend on what you can stick to long-term. Consistency is the key to weight loss success.
“A patient who tolerates semaglutide perfectly but feels terrible on tirzepatide will lose more weight on semaglutide because consistency beats potency every time,” explains Dr. Bronwyn Holmes, MD, a board-certified physician at Eden Health.
Tirzepatide vs. Semaglutide: Which is safer?
Research suggests that both medications are equally safe. “Neither is inherently ‘safer’ than the other — these medications both require medical screening for contraindications,” explains Holmes. “Safety really comes down to proper dosing and patient selection by a licensed provider.”
A 2025 review that assessed the safety profiles of both drugs found that the most common adverse effects are the same for both tirzepatide and semaglutide, namely, nausea, vomiting and diarrhea. Still, tirzepatide was linked to fewer reported side effects overall.
Also worth noting: A 2025 study that compared FDA Adverse Event reports that people are less likely to report acute kidney injury with tirzepatide than with semaglutide. Another 2025 review revealed that injection-site reactions are more likely with tirzepatide than with semaglutide (but keep in mind these reactions are almost always mild and temporary).
Who shouldn’t take tirzepatide or semaglutide?
Tirzepatide and semaglutide aren’t considered safe or suitable for anyone:
- With medullary thyroid cancer
- With multiple endocrine neoplasia syndrome type-2 (MEN 2)
- Who’s had severe hypersensitivity reactions to GLP-1 agonists (like anaphylaxis and angioedema)
- Who’s pregnant
Tirzepatide vs. semaglutide average cost
The cost of tirzepatide or semaglutide prescriptions depends mainly on whether your insurance covers it or if you are paying out of pocket. If your insurance covers it, then you’ll pay significantly less than someone without.
If insurance doesn’t cover your prescription, the average cost of brand-name tirzepatide (Mounjaro and Zepbound) is around $1,000 to $1,200 per month, while the average cost of brand-name semaglutide (Wegovy and Ozempic) is around $900 to $1,700 per month.
Many commercial insurance plans aren’t covering GLP-1 medications for weight loss, says Dr. Peter Balazs, MD, a hormone and weight loss doctor in New Jersey. With insurance, though, the cost of semaglutide or tirzepatide for weight loss can be as low as $25 to $100 per month.
| GLP-1 drug | Cost out of pocket | Cost with insurance |
|---|---|---|
| Ozempic (semaglutide) | $900-1,000/month | $25-150/month |
| Wegovy (semaglutide) | $1,300-1,700/month | $25-150/month |
| Mounjaro (tirzepatide) | $1,000-1,200/month | $25-150/month |
| Zepbound (tirzepatide) | $1,000-1,200/month | $25-150/month |
Other factors that can affect the price include:
- The pharmacy you use
- Whether you have any manufacturer coupons (can bring the cost down to as low as $25 per month)
- Whether you’re taking a brand name medication or compounded version (compound versions tend to be cheaper)
According to Balazs, the companies behind the popular brand names for tirzepatide and semaglutide often offer low-cost starter doses. It’s the maintenance doses that can cost significantly more.
Tirzepatide vs. semaglutide side effects
According to recent research, tirzepatide and semaglutide share many of the most common side effects, including gastrointestinal symptoms like:
- Nausea
- Vomiting
- Diarrhea
- Constipation
Up to 70% of people who take these medications experience some kind of gastrointestinal (GI) issue. Holmes says some patients report slightly less nausea with tirzepatide than with semaglutide — but the reason for this isn’t clear yet. According to Holmes, these side effects tend to be the strongest during the first four weeks while your provider is increasing your dose of the medication.
Tirzepatide vs. semaglutide adverse effects
According to Dr. Jay Luthar, MD, founder of Boston-based Lutanen Health, both medications share the same FDA black box warning about a risk of thyroid tumors. Keep in mind, though, that this is based on results from rodent studies, so it’s still unclear whether these medications contribute to thyroid tumors in humans.
Some of the other safety warnings on the label for both products include the following adverse events:
- Acute pancreatitis
- Acute gallbladder disease
- Hypoglycemia
- Acute kidney injury
- Diabetic retinopathy complications (in people with type 2 diabetes)
- Suicidal behavior and thoughts
Tirzepatide vs. semaglutide: Dosage
Both tirzepatide and semaglutide are once-weekly injections, with dosages gradually increasing over time. Once you’ve gotten closer to reaching your weight loss goal, you’ll enter the “maintenance phase,” during which your dosage stays the same week over week.
For semaglutide, the starting weekly dose is typically around 0.25 milligrams and the maximum dose is up to 2.4 milligrams, according to Balazs. For tirzepatide, the starting weekly dose is around 2.5 milligrams and the maximum dose is up to 15 milligrams.
“The volume of medication is different, but the strategy — start low and go slow to minimize side effects — is identical,” explains Holmes.
According to Luthar, dosages for tirzepatide typically increase by around 2.5 milligrams every four weeks, while dosages for semaglutide increase by around 0.25 to 0.5 milligrams every four weeks.
How do you choose between tirzepatide and semaglutide?
“There is no single best GLP-1 medication for every patient,” says Niazi. “The best option is the one that is safe, well tolerated and effective for that individual.”
According to Chatham, which medication is most effective for you depends on your medical history, underlying conditions and long-term health goals. “Because of its strong cardiovascular data, semaglutide may be a better option for patients with cardiovascular disease,” she explains. “But patients with sleep apnea may benefit more from tirzepatide.”
If you only have a modest amount of weight to lose, Holmes says semaglutide might be the first choice as it’s the “gold standard” with more long-term, established clinical data. If you aren’t achieving your desired results with semaglutide, or if you have type 2 diabetes with severe insulin resistance, she often suggests switching to tirzepatide.
“For patients with a higher BMI or more stubborn metabolic resistance, tirzepatide is often the more powerful lever to pull,” adds Holmes.
Luthar agrees that tirzepatide wins out when it comes to maximizing weight loss. However, there are some cases in which he’d prescribe semaglutide instead, including if you:
Frequently asked questions
Is tirzepatide better than semaglutide?
Several studies have shown that tirzepatide is more effective than semaglutide, but it all depends on how your body responds to the drug
How long does it take to lose 20 lbs on tirzepatide?
Depending on your body, lifestyle and goals, it can take between three and six months to lose 20 pounds on tirzepatide.
What should you avoid while taking tirzepatide?
Don’t rely on hormonal birth control pills alone to prevent pregnancy while on tirzepatide, says Luthar. Tirzepatide slows the rate at which your stomach empties out, which can then affect the way your body absorbs oral medications — and not just birth control, either.
It’s also super important to avoid letting yourself get dehydrated while on tirzepatide. According to Balazs, some GI side effects like vomiting and diarrhea can cause you to lose a lot of fluid and essential minerals, so make it a point to drink plenty of water — and consider adding electrolytes, too.
You should also avoid very high-fat, greasy, and fried foods, according to Holmes. “Because the medication slows digestion, fatty foods sit in the stomach longer and are the number one trigger for severe nausea and vomiting,” she explains.
If you’re taking insulin to treat type 1 or type 2 diabetes, you probably shouldn’t keep taking the same dose, says Dr. Maria Teresa Anton, MD, an endocrinologist and educator with Pritikin Longevity Center. According to Anton, your doctor will likely reduce your dose of insulin while you’re taking tirzepatide in order to prevent low blood sugar.
Each of these GLP-1 medications provides important safety information on its website, including possible side effects from taking the drug. Always seek the advice of your physician or other qualified healthcare provider concerning questions you have before starting, stopping or modifying any treatment or medication.
Source link
